Gorgas Gregory D.'s Form 4 filing
Artelo Biosciences, Inc. (ARTL) · filed Aug 12, 2022
- Accession no.
- 0001640334-22-001760
- Filed
- Aug 12, 2022
- Trade date
- Aug 12, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $4.80K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gorgas Gregory D.CIK 0001526251 | Director, Officer (Pres, CEO, CFO, Treas & Secr) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | Common Stock | PPurchaseAcquired | +1,200 | $4.00 | +$4,800 | 2,400 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.